Elmira Vagapova

Statistics

Publications

Citations

222

H-Index

Active since

2018

Affiliations

Engelhardt Institute of Molecular Biology(Current)

Moscow Power Engineering Institute

University Medical Center Hamburg-Eppendorf

Genetic Technologies (Australia)

Moscow Institute of Physics and Technology

Elmira Vagapova is an author at Engelhardt Institute of Molecular Biology specializing in pharmacology, neuroblastoma biology, and cancer pharmacology.

Publications per year

2018–2021

Publications

The Role of TAL1 in Hematopoiesis and Leukemogenesis

Elmira Vagapova, Pavel Spirin, Timofey Lebedev et al. · Acta Naturae · 2018 · 58 citations · Full text

Life Sciences, Hematology, Molecular Biology +15

Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia

Timofey Lebedev, Elmira Vagapova, Pavel Spirin et al. · Frontiers in Oncology · 2019 · 44 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis

Elmira Vagapova, Timofey Lebedev, Vladimir Prassolov · Scientific Reports · 2021 · 43 citations · Full text

Pharmacy, Molecular Medicine, Pharmacology +15

Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes

Timofey Lebedev, Elmira Vagapova, Pavel Spirin et al. · Oncogene · 2021 · 33 citations · Full text

Medicine, Oncology, Pharmacology +15

Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs

Elmira Vagapova, Timofey Lebedev, K A Ivanenko et al. · Biomedicines · 2021 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 7